Barclays Initiates Coverage on GE HealthCare Technologies (NASDAQ:GEHC)

Investment analysts at Barclays started coverage on shares of GE HealthCare Technologies (NASDAQ:GEHC) in a research report issued on Monday, Marketbeat reports. The brokerage set an “equal weight” rating and a $86.00 price target on the stock. Barclays‘s price target indicates a potential upside of 18.88% from the stock’s current price.

Other equities research analysts have also issued research reports about the company. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Morgan Stanley set a $74.00 price target on GE HealthCare Technologies in a research report on Thursday, September 18th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of GE HealthCare Technologies in a research report on Saturday, September 27th. BTIG Research increased their price target on GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research report on Monday. Finally, Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $85.20.

GE HealthCare Technologies Price Performance

GEHC opened at $72.34 on Monday. The stock’s 50-day moving average price is $74.36 and its 200 day moving average price is $72.16. GE HealthCare Technologies has a 12-month low of $57.65 and a 12-month high of $94.80. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The firm has a market cap of $33.03 billion, a price-to-earnings ratio of 14.82, a PEG ratio of 2.74 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the prior year, the company earned $1.00 EPS. GE HealthCare Technologies’s revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, sell-side analysts expect that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Bessemer Group Inc. grew its stake in GE HealthCare Technologies by 24.3% during the 1st quarter. Bessemer Group Inc. now owns 6,671 shares of the company’s stock worth $538,000 after buying an additional 1,306 shares during the last quarter. Flagship Harbor Advisors LLC grew its stake in GE HealthCare Technologies by 17.4% during the 1st quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company’s stock worth $278,000 after buying an additional 511 shares during the last quarter. Lineweaver Wealth Advisors LLC purchased a new position in GE HealthCare Technologies during the 2nd quarter worth approximately $592,000. Wealth Enhancement Advisory Services LLC grew its stake in GE HealthCare Technologies by 23.8% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company’s stock worth $4,105,000 after buying an additional 9,769 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its stake in GE HealthCare Technologies by 52.7% during the 1st quarter. Farther Finance Advisors LLC now owns 4,493 shares of the company’s stock worth $357,000 after buying an additional 1,550 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.